What: Researchers are testing innovative methods to better control maternal blood pressure, aiming to improve postpartum outcomes.
Key line: [Details not provided].
Source: MedPage Today.
Washington Post columnist Heather Long explains that higher fertility rates are linked to more equitable sharing of housework between couples.
New York introduces a shield law to protect doctors who prescribe abortion medications.
The Cut’s Beauty Editor examines Botox resistance—a rare phenomenon where antibodies may reduce the effectiveness of neuromodulators like Botox.
Women voice frustrations over intrusive social media ads during perimenopause.
A study finds that higher white blood cell counts in postmenopausal women may signal severe COVID-19.
An analysis of five years of U.S. maternal mortality data reveals significant state-to-state differences in causes of death.
The Trump IVF Executive Order does not make IVF free but instead asks for policy recommendations to lower costs, marking an initial step.
A study comparing sisters of women with and without pregnancy complications found that genetic and environmental factors may drive cardiovascular disease risk.
A study finds that postmenopausal women are significantly more at risk for long COVID compared to men.
A retrospective study found that preconception use of GLP-1 medications was associated with reduced risks of several adverse pregnancy outcomes.
Cheryl Wishhover delivers a witty review of celebrity menopause products, questioning their true benefits and efficacy.
The abrupt cancellation of NIH meetings may hinder critical medical research.
One blood pressure medication outperformed another, potentially lowering postpartum readmission rates.
A report highlights confusion over Tennessee’s recent Medicaid expansion for postpartum care.
A JAMA study finds that in states with abortion bans, a modest increase in fertility is accompanied by a significant rise in infant mortality rates.
A randomized control trial found that postpartum women treated with nifedipine had a dramatically lower readmission rate than those on labetalol.
Research shows the causes of maternal mortality differ widely from state to state.
RFK, Jr. is sworn in as HHS secretary and takes a dig at previous agency messaging while promising “the truth” so mothers can make informed decisions.
Exclusive subscriber content: a comprehensive report on upcoming shifts in women’s health and a 2024 stories database.
A marijuana business trade publication reports that some producers are eyeing cannabis-based treatments for women’s health issues.